Written by the Nuvirox Research Team
Key Points
- Not all allergy medications cause drowsiness — first-generation antihistamines like diphenhydramine (Benadryl) impair alertness significantly more than second-generation options like cetirizine or fexofenadine.
- Even "non-drowsy" second-generation antihistamines carry some sedation risk — cetirizine causes mild drowsiness in about 14% of users versus roughly 6% on placebo in controlled trials.
- Diphenhydramine's psychomotor impairment can persist into the next day even when the person doesn't subjectively feel drowsy, based on PET imaging research.
Short answer: it depends heavily on which antihistamine you're taking, and the differences between them are large and well documented. Older, first-generation antihistamines cross into the brain freely and cause substantial drowsiness and cognitive impairment. Newer, second-generation options were specifically designed to avoid this — and mostly succeed, though "non-drowsy" doesn't mean zero risk for every drug in that category.
Why do some allergy medications knock you out and others don't?
It comes down to whether the drug crosses the blood-brain barrier. Histamine H1 receptors exist both in your immune system (where blocking them relieves allergy symptoms) and in your brain (where histamine helps maintain wakefulness). First-generation antihistamines like diphenhydramine are small, lipophilic molecules that cross into the brain easily and block those wakefulness-promoting receptors there, which is exactly why diphenhydramine is also sold as a sleep aid. Second-generation antihistamines like cetirizine, loratadine, and fexofenadine were chemically engineered to be larger and less fat-soluble, so far less of the drug reaches the brain.
How much more sedating is Benadryl than the newer options?
Substantially more, based on head-to-head trial data. A double-blind randomized controlled trial comparing a single 50 mg dose of diphenhydramine against desloratadine (5 mg) and placebo in 204 people found diphenhydramine significantly impaired working memory, psychomotor speed, reasoning and computation, and divided attention compared to both desloratadine and placebo — with no significant differences between desloratadine and placebo.1 A systematic review pooling 43 randomized, placebo-controlled trials found diphenhydramine was associated with meaningfully worse performance across cognitive measures (effect size 0.31) compared with second-generation antihistamines, with the clearest effects on self-report, attention, and evoked brain potentials.2
Is cetirizine really "non-drowsy," or is that marketing?
It's mostly true, but with a real caveat. In controlled data, cetirizine causes mild drowsiness in roughly 13.7% of users compared to about 6.3% on placebo — a real, measurable increase, just far smaller than diphenhydramine's.3 A systematic review of fexofenadine specifically found it consistently non-sedating even at doses well above the standard recommendation, with one exception: a study of naval flight personnel found cetirizine impaired cognitive skills relevant to piloting under both normal and low-oxygen conditions, while fexofenadine performed comparably to placebo.4 If you need to be fully sharp — driving, operating equipment, an exam — fexofenadine has the cleanest track record among the common over-the-counter options in these trials.
What human studies actually show
Simons et al. compared the CNS effects of single doses of six different H1-antagonists in 15 healthy subjects using both an objective measure (P300 latency, a marker of cognitive processing speed) and subjective somnolence ratings. Diphenhydramine was the only drug to significantly slow P300 latency compared to baseline and placebo, while subjective somnolence was elevated after cetirizine, ketotifen, and diphenhydramine alike — underscoring that how sedated people feel and how impaired their brain actually is don't always move together.5
PET imaging research on diphenhydramine taken at night as a sleep aid found residual sedative effects detectable into the next day, even measured objectively via brain receptor occupancy — a "hangover" effect that isn't always something the person notices subjectively.6
Honest counterweight: Results for cetirizine specifically are genuinely mixed across the literature. A meta-analysis found cognitive impairment with cetirizine at doses of 10 mg or higher (the standard recommended dose) in a number of individual studies, even though its overall sedation rate is far lower than diphenhydramine's.2 "Second-generation" is not a single uniform category of risk.
What this fatigue won't be, and when it's more than the medication
Antihistamine-related drowsiness should track predictably with dosing — worse a couple of hours after taking it, better as it wears off. If you're consistently exhausted on days when you haven't taken an antihistamine at all, or if fatigue persists well beyond the drug's expected duration, the medication likely isn't the full explanation, and it's worth considering allergy-season fatigue more broadly, which has its own separate drivers like disrupted sleep from congestion, similar to the mechanisms behind morning grogginess and sleep inertia.
Which antihistamines are least likely to make you tired?
Based on the trial evidence above, fexofenadine has the most consistent record of non-sedation across doses. Loratadine and desloratadine are non-impairing at standard doses in most studies, though some show mild effects at higher-than-recommended doses. Cetirizine sits in the middle — low but real sedation risk, more pronounced in some individuals and at the higher end of its dose range. Diphenhydramine and other first-generation antihistamines (chlorpheniramine, doxylamine) carry the clearest and most consistent sedation and next-day impairment risk of the group.
FAQ
If I don't feel drowsy after taking Benadryl, does that mean I'm not impaired?
Not necessarily. The P300 latency research above found diphenhydramine slowed objective cognitive processing even in some cases where subjective drowsiness didn't track perfectly with it, and PET research shows next-day residual sedation that people often don't consciously notice.
Why does cetirizine make some people tired and not others, if it's "non-drowsy"?
Individual variation in metabolism, body size, and sensitivity to the drug all play a role, and the trial data itself shows a real, if modest, increase in drowsiness with cetirizine compared to placebo — it's a matter of degree, not an all-or-nothing effect.
Is it safe to take a first-generation antihistamine like Benadryl every night for allergies?
That's a question for your doctor or pharmacist, particularly for older adults, since research on diphenhydramine links regular first-generation antihistamine use to increased fall risk and cognitive effects, distinct from the acute single-dose drowsiness discussed here.
Do allergy medications interact with NAD+ precursor supplements?
There's no established pharmacological interaction between second-generation antihistamines and nicotinamide riboside in the research literature. As always, mention all medications and supplements you're taking to your doctor or pharmacist.
FROM NUVIROX
Why we formulated NAD+ Restore
Each two-capsule serving delivers 500 mg of nicotinamide riboside chloride (NR) — one of the two most-researched NAD+ precursors, within the dose range used in published human trials. We paired it with 150 mg trans-resveratrol and 50 mg quercetin, polyphenols studied alongside NAD+ pathways for cellular health support, plus 10 mg of fenugreek-derived galactomannans to support absorption.
Every order is backed by a 60-day money-back guarantee — long enough to actually evaluate it the way the research says you should.
Learn more about NAD+ Restore →The bottom line
Allergy medication drowsiness isn't uniform, and the research draws a clear line: first-generation antihistamines like diphenhydramine cause substantial, well-documented cognitive impairment, while second-generation options are meaningfully safer for daytime alertness — with fexofenadine having the cleanest record and cetirizine carrying a small but real sedation risk. If daytime tiredness is a problem, which specific antihistamine you're taking is worth a second look before assuming it's unrelated.
References
- Randomized controlled trial (diphenhydramine vs desloratadine vs placebo, n=204). Summarized in: "Diphenhydramine (e.g., Benadryl)." Cognitive Vitality for Researchers, Alzheimer's Drug Discovery Foundation.
- Systematic review/meta-analysis of 43 RCTs on second-generation antihistamine cognitive effects, summarized in HCPLive coverage of Spangler et al. meta-analysis.
- Randomized controlled trial data on cetirizine vs placebo sedation rates (13.7% vs 6.3%), summarized via clinical evidence review, droracle.ai.
- "Why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic review." Curr Med Res Opin. 2024. doi: 10.1080/03007995.2024.2378172.
- Simons FE, et al. Comparison of CNS effects of six H1-antagonists (P300 latency and somnolence). Summarized in: Classification of Sedating Antihistamines, Medsafe NZ.
- "Next-Day Residual Sedative Effect After Nighttime Administration of an Over-the-Counter Antihistamine Sleep Aid, Diphenhydramine, Measured by Positron Emission Tomography." Referenced in Tandfonline fexofenadine systematic review, 2024.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.